Madrigal Pharmaceuticals
Mary-Jo Dempsey is a seasoned professional with extensive experience in investor relations and executive support within the pharmaceutical industry. Currently serving as a Consultant, Investor Relations Coordinator at Madrigal Pharmaceuticals since February 2024, Mary-Jo previously held roles at Amgen, Horizon, and Takeda Pharmaceuticals, providing crucial administrative assistance to various senior executives. Key responsibilities included coordinating communications, managing calendars, and facilitating meetings to enhance operational efficiency. Mary-Jo began a career in administration in 1987 and has held progressively responsible positions at leading companies, demonstrating a strong commitment to collaboration and effective communication throughout her career. Education includes a Management Certification & General Business from UC Irvine and further studies at Orange Coast College.
This person is not in any teams
This person is not in any offices
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.